SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Imatron (IMAT) -- Ignore unavailable to you. Want to Upgrade?


To: Gerald Walls who wrote (127)9/10/1998 10:39:00 PM
From: Kerry C. Smith  Read Replies (1) | Respond to of 138
 
Gerald has provided food for thought, I wish we could get some more input on this board from the medical community. I talked to one doctor who only knew of this tech from what he read in the Newsweek article. I believe there are plenty of middle-class people who will pay for this scan when the story gets out a little more and some of these studies are completed. I know of a prominent judge in this area who credits the machine with saving his life.
I believe the stock got hit today based on confusion and might just be another buying opportunity. On CNBC, General Electric CEO Jack Welch was interviewed at the rollout of a new powerful CT scanner. His presence there made it seem like a big deal. CNBC owned by GE and eager to please the boss sitting right there gushed about how powerful this scanner was. The confusion lies in the fact it is also called a CT scanner like the Ultrafst CT. Even I was a little concerned until I checked with the company, They were fully aware of the announcement beforehand and were not concerned. The GE scanner is not as powerful. It is used as a general scanner and not a heart diagnostic tool. It is not being sold as part of the heart package and is not capable of delivering high quality images of the heart. The GE tech is completely different. EBCT is patented and vastly superior. In fact any exposure that GE gets will help sales of the ULTRFAST CT sales because soon the GE salesman will be selling the ULTRAFAST as part of their heart package. I knew there was no competing tech on the horizon, however it always helps to hear it again. I was just reading that Boris Yeltsin was scanned with Ultrafast to evaluate his implanted bypass grafts from open heart surgery to ensure his recent chest infection had not affected his heart. I know the company would like to scan more high profile people to help get the story out.



To: Gerald Walls who wrote (127)9/11/1998 3:31:00 PM
From: Chucky  Read Replies (1) | Respond to of 138
 
Gerald, Re:"To make the calculation easy assume that after copay the drug is $100 per month. 20 years at $100 per month is nearly a quarter of a million dollars."

How much do these HMO's get in premiums? I would think it would be over $1000/year. Therefore until age 65 they paid out >$65,000; however, the company should have made at least a hundred thousand on the investment. How much does an implantable defibrillator cost to remedy an ailing heart? The device alone is $20K. The procedure, while minimally invasive, along with the stay in the hospital should cost another $10K.
That is an awful lot of money to pay for someone that might die and therefore stop paying premiums in the next couple years as opposed to someone who stays relatively healthy on medication for the next 20.

btw, to make the calculation easier
$100 * 12 months = $1,200 per year
$1,200 * 20 years = $24,000
;o)

Medications are still relatively cheap if they can keep people healthy. It would seem advantageous to the HMO's to assure the customer's health as long as they (both the customer and the HMO) are still paying and avoid shelling out the lump sum close to their death or transfer to someone else's care.

Later
Chucky